Jonathan Gerber赞助的临床试验
总计1846个结果
-
Brigham and Women's HospitalErbe USA Incorporated尚未招聘
-
Weill Medical College of Cornell UniversityNational Center for Advancing Translational Sciences (NCATS); Brain & Behavior Research Foundation 和其他合作者完全的
-
Pusan National University HospitalErbe USA Incorporated招聘中
-
Brigham and Women's HospitalDana-Farber Cancer Institute; United States Department of Defense尚未招聘
-
Bruno BockornyDana-Farber Cancer Institute; Agenus Inc.尚未招聘
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.招聘中
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South Korea招聘中
-
Centro de Estudio de Estado y SociedadDana-Farber Cancer Institute; Deakin University完全的
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI); Dana-Farber Cancer Institute完全的
-
Jennifer R. Brown, MD, PhDAstraZeneca; TG Therapeutics, Inc.主动,不招人
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; Pharmacyclics LLC.完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Prometheus Laboratories; Miltenyi Biomedicine GmbH主动,不招人
-
Dana-Farber Cancer InstituteKaryopharm Therapeutics Inc; William Lawrence and Blanche Hughes Foundation主动,不招人复发性急性淋巴细胞白血病 (ALL) | 难治性急性淋巴细胞白血病 (ALL) | 复发性急性髓性白血病 (AML) | 难治性急性髓性白血病 (AML) | 复发性混合谱系白血病 | 难治性混合谱系白血病 | 复发性双表型白血病 | 难治性双表型白血病 | 急变期的慢性粒细胞白血病 (CML)美国
-
Lumicell, Inc.National Cancer Institute (NCI); Massachusetts General Hospital; Dana-Farber Cancer Institute完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's Hospital完全的
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Amgen完全的
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Pfizer; Beth Israel Deaconess Medical Center完全的
-
Massachusetts General HospitalPfizer; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Dana-Farber Cancer Institute完全的
-
Massachusetts General HospitalNovartis; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center完全的
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital终止
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Brigham and Women's Hospital完全的
-
James Cleary, MD, PhDLustgarten Foundation; Arcus Biosciences, Inc.招聘中
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI); Dana-Farber Cancer Institute招聘中
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Massachusetts Institute of Technology招聘中
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South Korea主动,不招人
-
Kevin BarberAlcon Research; Eric Rosenberg, D.O.,M.Sc.Eng.完全的
-
Boston Children's HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; Schering-Plough完全的
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Columbia University; Schering-Plough完全的
-
Massachusetts General HospitalGlaxoSmithKline; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center完全的
-
Mark Pomerantz, MDMerck Sharp & Dohme LLC; Rainier Therapeutics终止
-
Suzanne George, MDNovartis; Pfizer; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; AstraZeneca完全的
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Brigham and Women's Hospital完全的
-
University Hospital, LilleStallergenes Greer; Région Nord-Pas de Calais, France主动,不招人
-
Filipa Lynce, MDMerck Sharp & Dohme LLC; Zentalis Pharmaceuticals尚未招聘乳腺癌 | 三阴性乳腺癌 | 乳腺癌女性 | HER2 阴性乳腺癌 | 激素受体阴性乳腺癌三联美国
-
Dana-Farber Cancer InstituteAdenoid Cystic Carcinoma Research Foundation; Gateway for Cancer Research招聘中
-
Dana-Farber Cancer InstituteJohns Hopkins University; GlaxoSmithKline; Translational Breast Cancer Research Consortium招聘中乳腺癌 | I期乳腺癌 | II期乳腺癌 | HER2 阴性乳腺癌 | III期乳腺癌 | 有害的 PALB2 基因突变 | 种系 BRCA1 基因突变 | 种系 BRCA2 基因突变美国
-
Beth Israel Deaconess Medical CenterJohns Hopkins University; Dana-Farber Cancer Institute; AstraZeneca主动,不招人转移性乳腺癌 | 浸润性乳腺癌 | BRIP1基因突变 | PALB2基因突变 | ATM基因突变 | CHEK2基因突变 | NBN基因突变 | RAD51基因突变 | 体细胞突变乳腺癌 (BRCA1) | 体细胞突变乳腺癌 (BRCA2)美国
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's Hospital主动,不招人
-
Geoffrey Shapiro, MD, PhDEli Lilly and Company; AstraZeneca完全的
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South Korea完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical Center完全的
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Brigham and Women's Hospital完全的急性髓性白血病 | 慢性粒单核细胞白血病 | 骨髓增生异常综合征-难治性贫血伴原始细胞过多美国